Perrigo Company M&A Summary
Perrigo Company has acquired 33 companies, including 4 in the last 5 years. A total of 7 acquisitions came from private equity firms. It has also divested 9 assets.
Perrigo Company’s largest acquisition to date was in 2013, when it acquired Elan for $8.6B. It’s largest disclosed sale occurred in 2017, when it sold TYSABRI to Royalty Pharma for $2.9B. Perrigo Company has acquired in 13 different US states, and 10 countries. The Company’s most targeted sectors include medical products (33%) and life science (23%).
M&A Summary
-
M&A Total Activity40
- M&A Buy Activity31
- M&A Sell Activity9
- Total Sectors Invested 8
- Total Countries Invested 10
- M&A Buy/Sell Connections 23